IMCD 将来の成長

Future 基準チェック /26

IMCD利益と収益がそれぞれ年間8.7%と5.3%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に17.3% 8.8%なると予測されています。

主要情報

8.7%

収益成長率

8.8%

EPS成長率

Trade Distributors 収益成長	8.9%
収益成長率	5.3%
将来の株主資本利益率	17.3%
アナリストカバレッジ	Good
最終更新日	18 Nov 2024

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

BATS-CHIXE:IMCDA - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	5,369	346	440	458	13
12/31/2025	5,063	310	402	423	14
12/31/2024	4,741	278	334	399	14
6/30/2024	4,559	281	361	395	N/A
3/31/2024	4,511	287	372	407	N/A
12/31/2023	4,463	292	383	420	N/A
9/30/2023	4,526	290	386	418	N/A
6/30/2023	4,590	289	390	416	N/A
3/31/2023	4,606	301	334	358	N/A
12/31/2022	4,622	313	278	299	N/A
9/30/2022	4,357	296	213	232	N/A
6/30/2022	4,091	279	149	165	N/A
3/31/2022	3,772	243	163	181	N/A
12/31/2021	3,453	207	178	196	N/A
9/30/2021	3,257	184	211	229	N/A
6/30/2021	3,060	162	244	262	N/A
3/31/2021	2,924	141	229	247	N/A
12/31/2020	2,787	120	214	232	N/A
9/30/2020	2,752	114	183	203	N/A
6/30/2020	2,717	108	152	173	N/A
3/31/2020	2,711	108	154	174	N/A
12/31/2019	2,705	108	156	174	N/A
9/30/2019	2,670	109	141	157	N/A
6/30/2019	2,636	111	126	139	N/A
3/31/2019	2,512	105	114	127	N/A
12/31/2018	2,389	100	102	114	N/A
9/30/2018	2,260	94	87	102	N/A
6/30/2018	2,131	88	73	90	N/A
3/31/2018	2,022	83	N/A	102	N/A
12/31/2017	1,912	77	N/A	114	N/A
9/30/2017	1,840	77	N/A	112	N/A
6/30/2017	1,768	76	N/A	110	N/A
3/31/2017	1,743	75	N/A	105	N/A
12/31/2016	1,718	73	N/A	100	N/A
9/30/2016	1,706	71	N/A	102	N/A
6/30/2016	1,693	69	N/A	104	N/A
3/31/2016	1,615	65	N/A	95	N/A
12/31/2015	1,537	62	N/A	86	N/A
9/30/2015	1,465	57	N/A	79	N/A
6/30/2015	1,392	53	N/A	71	N/A
3/31/2015	1,386	34	N/A	48	N/A
12/31/2014	1,366	20	N/A	37	N/A
9/30/2014	1,350	6	N/A	28	N/A
6/30/2014	1,334	-8	N/A	19	N/A
3/31/2014	1,279	-3	N/A	43	N/A
12/31/2013	1,242	-5	N/A	8	N/A

アナリストによる今後の成長予測

収入対貯蓄率: IMCDAの予測収益成長率 (年間8.7% ) は貯蓄率 ( 2.1% ) を上回っています。

収益対市場: IMCDAの収益 ( 8.7% ) UK市場 ( 14.6% ) よりも低い成長が予測されています。

高成長収益: IMCDAの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: IMCDAの収益 ( 5.3% ) UK市場 ( 3.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: IMCDAの収益 ( 5.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: IMCDAの自己資本利益率は、3年後には低くなると予測されています ( 17.3 %)。

IMCD 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Recent updates

IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.

IMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group.

IMCD N.V., Annual General Meeting, Apr 25, 2025

IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024

Upcoming dividend of €2.24 per share

Full year 2023 earnings released: EPS: €5.14 (vs €5.50 in FY 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

New minor risk - Insider selling

IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited.

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory Board

IMCD N.V. to Report First Half, 2024 Results on Aug 02, 2024

First half 2023 earnings released: EPS: €2.68 (vs €3.11 in 1H 2022)

IMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc.

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd.

Upcoming dividend of €2.37 per share at 1.6% yield

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd.

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Parkash DyeChem Private Limited.

IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023

Now 20% undervalued after recent price drop

Now 22% undervalued

IMCD N.V. (ENXTAM:IMCD) acquired 100% of the shares in Kuni Chemical Co., Ltd.

First half 2022 earnings released

IMCD N.V. to Report Q1, 2023 Results on Apr 26, 2023

IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Welex S.A. Holdings (China) Limited.

IMCD N.V. Appoints Marcus Jordan as Chief Operating Office and New Member of the Management Board

IMCD Stops Its Business in Russia

Upcoming dividend of €1.62 per share

IMCD N.V. Proposes Dividend for the Year 2021

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Quelaris Internacional S.A.

Investor sentiment deteriorated over the past week

IMCD N.V. (ENXTAM:IMCD) agreed to acquire Polychem Handelsgesellschaft M.B.H.

First half 2021 earnings released: EPS €1.85 (vs €1.22 in 1H 2020)

IMCD N.V. (ENXTAM:IMCD) entered into an agreement to acquire Materias Quimicas De Mexico, S.A. De C.V.

Independent Member of Supervisory Board Michel G. Plantevin has left the company

Upcoming dividend of €1.02 per share

IMCD N.V. (ENXTAM:IMCD) acquired Shanghai Yuanhe Chemicals Co., Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired Andes Chemical Corp.

New 90-day high: €112

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

Full year 2020 earnings released: EPS €2.25 (vs €2.06 in FY 2019)

Revenue beats expectations

IMCD N.V. Announces Management Changes, Effective 26 February 2021

IMCD N.V. (ENXTAM:IMCD) acquired Millikan S.A. de C.V. and Banner Química S.A. de C.V.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire the personal care business of Ejder Kimya Ilaç Danismanlik Sanayi ve Ticaret A.S.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Pharmaceutical Business of Peak International Products B.V.

IMCD N.V. (ENXTAM:IMCD) acquired Oy Kokko-Fiber Ab.

IMCD N.V. has completed a Follow-on Equity Offering in the amount of €399.999964 million.

IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Siyeza Fine Chem Propriety Limited.

IMCD N.V. (ENXTAM:IMCD) completed the acquisition of pharmaceutical business of Develing International Trade (Shanghai) Co. Ltd.

IMCD N.V. (ENXTAM:IMCD) acquired VitaQualy Comercio de Ingredientes LTDA.

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘